Profile data is unavailable for this security.
About the company
Shaanxi Meibang Pharmaceutical Group Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of pesticide preparations. The Company's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
- Revenue in CNY (TTM)666.41m
- Net income in CNY32.72m
- Incorporated1998
- Employees939.00
- LocationShaanxi Meibang Pharmaceutical Group Co LtdHigh-Tech Industrial Development ZonePucheng County,XI'AN 715500ChinaCHN
- Phone+86 2 986183766
- Fax+86 2 989820615
- Websitehttp://www.meibang.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zhejiang Tuna Env Scn & Tech Co Ltd | 809.65m | -34.64m | 1.47bn | 846.00 | -- | 3.71 | -- | 1.82 | -0.1976 | -0.1976 | 3.98 | 1.90 | 0.4882 | 3.79 | 1.28 | 957,027.60 | -2.58 | -3.56 | -6.75 | -9.88 | 21.34 | 19.68 | -5.29 | -7.39 | 0.796 | -0.3986 | 0.6702 | -- | -0.1595 | 1.29 | -618.12 | -- | 15.50 | -- |
Ningxia Zhongke Biotechnology Co Ltd | 293.48m | -458.53m | 1.47bn | 731.00 | -- | 12.67 | -- | 5.02 | -0.6695 | -0.6695 | 0.4285 | 0.1698 | 0.0954 | 3.34 | 8.08 | 401,472.00 | -16.50 | -6.14 | -45.42 | -11.75 | -28.27 | -6.43 | -172.90 | -56.52 | 0.0488 | -3.16 | 0.73 | -- | -58.06 | -12.34 | -229.02 | -- | -4.73 | -- |
Zhejiang Jiaao Enprotech Stock Co Ltd | 2.52bn | -40.75m | 1.55bn | 1.21k | -- | 1.53 | -- | 0.6151 | -0.5305 | -0.5305 | 32.75 | 13.08 | 0.6291 | 4.55 | 19.70 | 2,074,546.00 | -0.9489 | 1.59 | -2.66 | 2.87 | 3.09 | 9.50 | -1.51 | 1.81 | 0.4439 | -0.2774 | 0.5766 | 29.42 | -16.98 | 20.73 | 106.44 | -47.77 | 62.42 | -- |
Shaanxi Meibang Pharmaceuticl Grp Co Ltd | 666.41m | 32.72m | 1.56bn | 939.00 | 47.58 | 1.34 | -- | 2.34 | 0.2421 | 0.2421 | 4.93 | 8.57 | 0.4276 | 1.62 | 2.31 | 709,697.40 | 2.10 | 8.61 | 2.54 | 12.57 | 29.91 | 36.78 | 4.91 | 13.69 | 2.31 | -- | 0.0596 | 15.66 | -22.85 | 9.77 | -60.33 | -0.6051 | 42.34 | -- |
Zhejiang Cady Industry Co Ltd | 711.99m | 114.02m | 1.57bn | 1.12k | 13.77 | 1.19 | -- | 2.20 | 0.9829 | 0.9829 | 6.14 | 11.34 | 0.4547 | 4.27 | 7.46 | 636,844.70 | 7.28 | -- | 8.62 | -- | 24.69 | -- | 16.01 | -- | 3.50 | -- | 0.0926 | -- | -3.58 | -- | -5.35 | -- | -- | -- |
Suzhou Longjie Special Fiber Co Ltd | 1.71bn | 39.70m | 1.58bn | 917.00 | 39.59 | 1.26 | -- | 0.9263 | 0.1844 | 0.1844 | 7.90 | 5.80 | 1.16 | 5.83 | 257.32 | 1,859,366.00 | 2.70 | 2.73 | 3.01 | 3.17 | 5.85 | 8.54 | 2.33 | 3.28 | 4.16 | -- | 0.0664 | 84.87 | 49.94 | -1.72 | 128.53 | -37.76 | 49.94 | -11.40 |
Zhejiang Hisun Biomaterials Co Ltd | 802.46m | 46.30m | 1.60bn | 383.00 | 34.63 | 1.08 | -- | 2.00 | 0.2284 | 0.2284 | 3.96 | 7.34 | 0.4005 | 5.24 | 19.52 | 2,095,207.00 | 2.31 | -- | 2.84 | -- | 12.78 | -- | 5.77 | -- | 2.10 | -- | 0.2166 | -- | 24.43 | -- | -7.41 | -- | -- | -- |
Shandong Cynda Chemical Co Ltd | 2.42bn | -156.07m | 1.65bn | 2.18k | -- | 0.8271 | -- | 0.6797 | -0.3718 | -0.3718 | 5.62 | 4.58 | 0.6828 | 2.67 | 6.93 | 1,112,224.00 | -4.34 | 6.37 | -7.21 | 9.16 | 8.47 | 23.74 | -6.36 | 7.48 | 0.8941 | -- | 0.2825 | 35.64 | -20.58 | 8.70 | -125.68 | -- | -10.16 | -- |
Data as of Jul 26 2024. Currency figures normalised to Shaanxi Meibang Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.45%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Gfund Management Co., Ltd.as of 31 Dec 2023 | 735.90k | 2.18% |
Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 327.20k | 0.97% |
CITIC-Prudential Fund Management Co., Ltd.as of 31 Dec 2023 | 287.80k | 0.85% |
Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 69.67k | 0.21% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 47.17k | 0.14% |
Guolian Fund Management Co. Ltd.as of 31 Dec 2023 | 16.00k | 0.05% |
Fortune & Royal Asset Management Co., Ltd.as of 31 Dec 2023 | 8.00k | 0.02% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 6.50k | 0.02% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 3.32k | 0.01% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 1.69k | 0.01% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.